Minerva Neurosciences (NERV) Net Margin (2020)

Minerva Neurosciences (NERV) posted Net Margin of 71.21% for Q2 2020.

Minerva Neurosciences (NERV) Net Margin (2020) Analysis & Trends

Minerva Neurosciences' Net Margin history runs 1 years deep, the most recent figure standing at 71.21% for Q2 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Margin (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	15.02%
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	34.53%
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	20.17%
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	30.33%
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Minerva Neurosciences	195.10 Mn	195.10 Mn	-	-

Download Data

Date	Value
Jun 30, 2020	71.21%